Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi, T L Lasho, Paola Guglielmelli, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1861-1869
Closed Access | Times Cited: 717

Showing 1-25 of 717 citing articles:

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5146
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 23, pp. 2209-2221
Open Access | Times Cited: 3536
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan, et al.
New England Journal of Medicine (2013) Vol. 369, Iss. 25, pp. 2379-2390
Open Access | Times Cited: 1851
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Ayalew Tefferi, Elisa Rumi, Guido Finazzi, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1874-1881
Open Access | Times Cited: 616
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg, Axel Karow, Ronny Nienhold, et al.
Blood (2014) Vol. 123, Iss. 14, pp. 2220-2228
Open Access | Times Cited: 577
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Jacob Grinfeld, Jyoti Nangalia, E. Joanna Baxter, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 15, pp. 1416-1430
Open Access | Times Cited: 528
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Ayalew Tefferi, Terra L. Lasho, Christy Finke, et al.
Leukemia (2014) Vol. 28, Iss. 7, pp. 1472-1477
Closed Access | Times Cited: 523
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eun Hee Kim, Janine O. Ilagan, Yang Liang, et al.
Cancer Cell (2015) Vol. 27, Iss. 5, pp. 617-630
Open Access | Times Cited: 503
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 4, pp. 310-318
Open Access | Times Cited: 471
Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms
Lorena Arranz, Abel Sánchez‐Aguilera, Daniel Martín-Pérez, et al.
Nature (2014) Vol. 512, Iss. 7512, pp. 78-81
Closed Access | Times Cited: 414
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
Elisa Rumi, Daniela Pietra, Cristiana Pascutto, et al.
Blood (2014) Vol. 124, Iss. 7, pp. 1062-1069
Open Access | Times Cited: 366
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eun Hee Kim, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 672-678
Open Access | Times Cited: 334
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel‐Wahab, Jie Gao, Mazhar Adli, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 12, pp. 2641-2659
Open Access | Times Cited: 309
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
Ayalew Tefferi, Terra L. Lasho, Kebede H. Begna, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 10, pp. 908-919
Open Access | Times Cited: 305
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
Francesco Passamonti, Toni Giorgino, Barbara Mora, et al.
Leukemia (2017) Vol. 31, Iss. 12, pp. 2726-2731
Open Access | Times Cited: 302
Myeloproliferative Neoplasms
Ayalew Tefferi, Animesh Pardanani
JAMA Oncology (2015) Vol. 1, Iss. 1, pp. 97-97
Closed Access | Times Cited: 295
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, et al.
Leukemia (2014) Vol. 28, Iss. 9, pp. 1804-1810
Closed Access | Times Cited: 292
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, et al.
Blood Advances (2016) Vol. 1, Iss. 1, pp. 21-30
Open Access | Times Cited: 288
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, et al.
Leukemia (2014) Vol. 28, Iss. 7, pp. 1494-1500
Open Access | Times Cited: 271
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
Nicolaus Kröger, H. J. Deeg, Eduardo Olavarría, et al.
Leukemia (2015) Vol. 29, Iss. 11, pp. 2126-2133
Open Access | Times Cited: 262
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho, et al.
Leukemia (2014) Vol. 28, Iss. 11, pp. 2206-2212
Closed Access | Times Cited: 257
Page 1 - Next Page

Scroll to top